Related Experiment Video
Updated: May 5, 2026

Biventricular Assessment of Cardiac Function and Pressure-Volume Loops by Closed-Chest Catheterization in Mice
Published on: June 15, 2020
Cardiac magnetic resonance imaging in pulmonary arterial hypertension
Andrew J Peacock1, Anton Vonk Noordegraaf
1Scottish Pulmonary Vascular Unit, Glasgow, UK. 2 Dept of Pulmonology, VU University Medical Center, Amsterdam, The Netherlands.
Abstract:
Cardiac magnetic resonance imaging (CMRI) provides accurate information about right ventricular (RV) mass, RV volumes and other markers of RV function. CMRI is proving to be a particularly useful tool in pulmonary arterial hypertension (PAH), as measures of RV function have been shown to be prognostic of long-term outcomes in this disease. Changes in RV function can also provide important information about a patient's disease course and response to treatment. As CMRI is noninvasive it can be used to regularly monitor patients with PAH, which is an important advantage over invasive right heart catheterisation. This review will explore the use of CMRI in the context of existing monitoring tools for PAH and will explore the forthcoming developments that are likely to be important in the future monitoring of patients with PAH.
Related Concept Videos
Imaging Studies for Cardiovascular System IV: CMRI
Mitral Stenosis II: Clinical features and Diagnostic Tests
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Aortic Regurgitation II: Clinical Features and Diagnostic Tests

